---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-305475"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2025-12-02T23:59:59+00:00"
generated_at: "2026-05-16T15:45:49.922760+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma stockholders elect directors and ratify auditor at 2025 annual meeting

## Summary
- 22,327,761 shares present (85.06% of outstanding); all proposals passed.
- Directors Dr. Jerel Banks (22,150,169 for) and Megan Boston (21,693,741 for) elected.
- Ratification of independent auditor approved: 22,252,834 for, 4,787 against.
- Advisory vote on executive compensation passed with 17,239,339 for, 4,939,686 against.

## SEC filing metadata
- accession: 0001193125-25-305475
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2025-12-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312525305475/0001193125-25-305475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312525305475/bntc-20251201.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-305475
- JSON: https://secwatch.observer/filing/0001193125-25-305475.json
- Plain text: https://secwatch.observer/filing/0001193125-25-305475.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.